Pattern Recognition Part 1

Chapter 089: Pattern Recognition Part 1 By 4:00 AM, Leah had already run the second day three different ways and killed herself in two of them. In one version, Priya noticed that Catherine's searches moved faster through shell-company names than through market reports. In another, David Choi asked for a draft before lunch and found too much NexGen risk in the outline. In the third, nothing went wrong at all, which frightened Leah most because success made people careless. She lay in the dark, listening to the city, and reminded herself that Catherine Marsh's job was not to win today. It was to last. At 6:30, the alarm gave her permission to move. She dressed with restraint: navy pencil skirt, cream blouse, low heels, hair arranged to keep the scar near her eyebrow hidden. Catherine's face in the mirror looked serious but not intense, competent but not hungry. Leah practiced the expression until Isabella disappeared behind it. The Moleskine held three pages from the first day: floor map, level-two limits, Halcyon gap, Geraldine Hoffman, possible routes to thirty-six. She read them once, then locked the notebook inside the false bottom of her bag. Official work first. Hidden work through official work. No shortcuts. The healthcare competitive landscape analysis was due in twelve days. Catherine would produce a report Priya could defend. Every search would also teach Leah how ThorneVault was built: what it indexed, what it buried, and where Martha's careful absences began. She arrived at 445 Park at 8:40, and this time the permanent badge opened the gate with a clean electronic chirp. The sound was small, but it changed the shape of the morning. Yesterday she had been permitted. Today she belonged in the system. At 8:52, she logged into ThorneVault and began with the categories the database offered without resistance: Company Profiles, Market Intelligence, Regulatory Filings, Internal Reports. Costa Holdings had fourteen medical-device subsidiaries. NexGen sat under Acquisitions - Pending. The historical acquisitions folder went back to 2015. Leah opened the oldest files first, because patterns hated chronology until someone forced them into it. MedCore Technologies, 2016: clean due diligence, complete financial section, normal board presentation. PrecisionMed, 2017: thorough regulatory review, no obvious gaps. Then Veritas Labs, 2018: half-length due diligence, thin financial analysis, missing competitive landscape, and one scanned handwritten note added after completion. Structured per HT directive. Do not circulate outside executive committee. The office noise fell away. HT was not Howard Thorne. In Thorne Group document shorthand, HT meant Helen Thorne when Martha wanted to hide behind her middle name. Martha Helen Thorne. A directive from Martha, attached to an intentionally incomplete acquisition review. Leah bookmarked the file under the landscape project and kept her breathing even. She opened the financial analysis. Veritas Labs had been acquired for thirty-eight million dollars, including a twenty-two-million-dollar loan from the Thorne Foundation Strategic Initiatives Fund. A charitable foundation had financed a for-profit acquisition inside the family's own corporate network. She wrote in Catherine's notebook: Veritas Labs acquisition. 2018. $38M total. $22M Foundation Strategic Initiatives Fund. Diligence incomplete under HT directive. Cross-reference Foundation PRI records. Program-related investment. Leah knew the term before the memo appeared, but seeing Martha use it made her jaw tighten. PRI language could make a private foundation investment look charitable if it was dressed in mission language and buried in the right tax section. The memo to the Foundation board did exactly that: healthcare mission, medical innovation, Section 4944, family strategic interests disguised as public benefit. The wording was careful enough to survive a lazy review and arrogant enough to reveal Martha's confidence. She had not hidden the self-dealing in a basement. She had filed it, labeled it, and trusted the architecture of wealth to make it invisible. Leah searched Strategic Initiatives Fund. Three more acquisition files surfaced between 2018 and 2022. Each showed the same ugly rhythm: abbreviated due diligence, executive restriction, Foundation money supporting a Costa Holdings acquisition. Total exposure: sixty-seven million dollars. The number sat on the screen with the cold weight of evidence. Not one transfer. Not one emergency bridge. A system. Leah felt the old training return, sharper than grief. Isabella Thorne had been taught to read companies as living organisms: revenue as breath, debt as pressure, governance as skeleton, related-party transactions as bruises someone hoped clothing would hide. Catherine Marsh was only doing her job. Isabella Thorne was doing the thing Martha had trained her to do before deciding she was disposable. The satisfaction was dangerous. It had texture: a click in the mind, a door unlocking. Leah let herself have only three seconds of it. Then she saved her official outline and returned to the market analysis. At 12:15, she took lunch in the thirty-fourth-floor cafeteria, choosing a table by the window with a view of the elevator bank. Half the room ate at speed. Junior analysts talked around salad containers. Mid-level managers checked phones between bites. Leah was halfway through a sandwich when a woman sat across from her without asking. Black hair. Gray pantsuit. Laptop bag with the Thorne Group logo. Mid-thirties. Sharp, assessing eyes. "Catherine, right? New hire in Market Analysis?" "Yes." "Rachel Okonkwo. Corporate Development, two floors up." The words placed her on thirty-six before Leah had to ask. "I heard David hired someone from the Whitfield referral. Whitfield's people are usually solid. How is the healthcare analysis going?" Leah set the sandwich down. Corporate Development. Thirty-sixth floor. Level three. Veritas might have crossed Rachel's desk before it crossed Catherine's screen. "Early days," Leah said. "The portfolio is more extensive than I expected." "It is. Costa has been aggressive for years. Some acquisitions make sense." Rachel's mouth tightened. "Some raise questions." Leah held Catherine's polite curiosity in place. "What kind of questions?" "Why certain targets were chosen. How valuations were justified. Whether the diligence was thorough." Rachel stirred her salad without taking another bite. "I worked on Veritas Labs in 2018. The report was abbreviated. I asked David about it. He told me it came from above his pay grade, and I should let it go." Above David's pay grade meant executive floor. It meant Martha. "I appreciate the context," Leah said. "I'll keep it in mind." Rachel looked at her long enough to make the cafeteria noise feel staged. "You are thorough. I can tell. Just be careful what you dig into around here. Some questions have answers people prefer buried." Then she stood and left. Leah did not follow her with her eyes. Catherine Marsh returned to her lunch. Leah counted Rachel's warning, her access, her Veritas history, and the possibility that Martha had sent her to watch the new analyst. Ally or test. Door or trap. Either way, the pattern had produced a person. When Leah went back to her desk, she wrote only one line in the safe notebook: Rachel Okonkwo - Corp Dev / 36 / Veritas / warned off. The thirty-sixth floor had just spoken first.